177 related articles for article (PubMed ID: 38430536)
1. Systemic Administration of Cowpea Mosaic Virus Demonstrates Broad Protection Against Metastatic Cancers.
Chung YH; Zhao Z; Jung E; Omole AO; Wang H; Sutorus L; Steinmetz NF
Adv Sci (Weinh); 2024 May; 11(18):e2308237. PubMed ID: 38430536
[TBL] [Abstract][Full Text] [Related]
2. Inactivated Cowpea Mosaic Virus in Combination with OX40 Agonist Primes Potent Antitumor Immunity in a Bilateral Melanoma Mouse Model.
Koellhoffer EC; Mao C; Beiss V; Wang L; Fiering SN; Boone CE; Steinmetz NF
Mol Pharm; 2022 Feb; 19(2):592-601. PubMed ID: 34978197
[TBL] [Abstract][Full Text] [Related]
3. In Situ Vaccination with Cowpea vs Tobacco Mosaic Virus against Melanoma.
Murray AA; Wang C; Fiering S; Steinmetz NF
Mol Pharm; 2018 Sep; 15(9):3700-3716. PubMed ID: 29798673
[TBL] [Abstract][Full Text] [Related]
4. Cowpea Mosaic Virus and Natural Killer Cell Agonism for In Situ Cancer Vaccination.
Koellhoffer EC; Steinmetz NF
Nano Lett; 2022 Jul; 22(13):5348-5356. PubMed ID: 35713326
[TBL] [Abstract][Full Text] [Related]
5. Cowpea Mosaic Virus Outperforms Other Members of the Secoviridae as In Situ Vaccine for Cancer Immunotherapy.
Beiss V; Mao C; Fiering SN; Steinmetz NF
Mol Pharm; 2022 May; 19(5):1573-1585. PubMed ID: 35333531
[TBL] [Abstract][Full Text] [Related]
6. In Vivo Fate of Cowpea Mosaic Virus In Situ Vaccine: Biodistribution and Clearance.
Affonso de Oliveira JF; Chan SK; Omole AO; Agrawal V; Steinmetz NF
ACS Nano; 2022 Nov; 16(11):18315-18328. PubMed ID: 36264973
[TBL] [Abstract][Full Text] [Related]
7. Injectable Hydrogel Containing Cowpea Mosaic Virus Nanoparticles Prevents Colon Cancer Growth.
Nkanga CI; Steinmetz NF
ACS Biomater Sci Eng; 2022 Jun; 8(6):2518-2525. PubMed ID: 35522951
[TBL] [Abstract][Full Text] [Related]
8. Inactivated Cowpea Mosaic Virus for In Situ Vaccination: Differential Efficacy of Formalin vs UV-Inactivated Formulations.
Jung E; Mao C; Bhatia M; Koellhoffer EC; Fiering SN; Steinmetz NF
Mol Pharm; 2023 Jan; 20(1):500-507. PubMed ID: 36399598
[TBL] [Abstract][Full Text] [Related]
9. Antibody Response against Cowpea Mosaic Viral Nanoparticles Improves
Shukla S; Wang C; Beiss V; Steinmetz NF
ACS Nano; 2020 Mar; 14(3):2994-3003. PubMed ID: 32133838
[TBL] [Abstract][Full Text] [Related]
10. In situ vaccination with cowpea mosaic virus elicits systemic antitumor immunity and potentiates immune checkpoint blockade.
Mao C; Beiss V; Ho GW; Fields J; Steinmetz NF; Fiering S
J Immunother Cancer; 2022 Dec; 10(12):. PubMed ID: 36460333
[TBL] [Abstract][Full Text] [Related]
11. In situ vaccination with cowpea mosaic virus nanoparticles suppresses metastatic cancer.
Lizotte PH; Wen AM; Sheen MR; Fields J; Rojanasopondist P; Steinmetz NF; Fiering S
Nat Nanotechnol; 2016 Mar; 11(3):295-303. PubMed ID: 26689376
[TBL] [Abstract][Full Text] [Related]
12. The unique potency of Cowpea mosaic virus (CPMV)
Shukla S; Wang C; Beiss V; Cai H; Washington T; Murray AA; Gong X; Zhao Z; Masarapu H; Zlotnick A; Fiering S; Steinmetz NF
Biomater Sci; 2020 Sep; 8(19):5489-5503. PubMed ID: 32914796
[TBL] [Abstract][Full Text] [Related]
13. Metastatic Colon Cancer Treatment Using S100A9-Targeted Cowpea Mosaic Virus Nanoparticles.
Chung YH; Volckaert BA; Steinmetz NF
Biomacromolecules; 2022 Dec; 23(12):5127-5136. PubMed ID: 36375170
[TBL] [Abstract][Full Text] [Related]
14. Synergistic combination therapy using cowpea mosaic virus intratumoral immunotherapy and Lag-3 checkpoint blockade.
Karan S; Jung E; Boone C; Steinmetz NF
Cancer Immunol Immunother; 2024 Feb; 73(3):51. PubMed ID: 38349406
[TBL] [Abstract][Full Text] [Related]
15. Plant Viral Nanoparticle Conjugated with Anti-PD-1 Peptide for Ovarian Cancer Immunotherapy.
Gautam A; Beiss V; Wang C; Wang L; Steinmetz NF
Int J Mol Sci; 2021 Sep; 22(18):. PubMed ID: 34575893
[TBL] [Abstract][Full Text] [Related]
16. The Potency of Cowpea Mosaic Virus Particles for Cancer In Situ Vaccination Is Unaffected by the Specific Encapsidated Viral RNA.
Jung E; Chung YH; Mao C; Fiering SN; Steinmetz NF
Mol Pharm; 2023 Jul; 20(7):3589-3597. PubMed ID: 37294891
[TBL] [Abstract][Full Text] [Related]
17. S100A9-Targeted Cowpea Mosaic Virus as a Prophylactic and Therapeutic Immunotherapy against Metastatic Breast Cancer and Melanoma.
Chung YH; Park J; Cai H; Steinmetz NF
Adv Sci (Weinh); 2021 Nov; 8(21):e2101796. PubMed ID: 34519180
[TBL] [Abstract][Full Text] [Related]
18. Cowpea Mosaic Virus Nanoparticles and Empty Virus-Like Particles Show Distinct but Overlapping Immunostimulatory Properties.
Wang C; Beiss V; Steinmetz NF
J Virol; 2019 Nov; 93(21):. PubMed ID: 31375592
[TBL] [Abstract][Full Text] [Related]
19. Cowpea mosaic virus stimulates antitumor immunity through recognition by multiple MYD88-dependent toll-like receptors.
Mao C; Beiss V; Fields J; Steinmetz NF; Fiering S
Biomaterials; 2021 Aug; 275():120914. PubMed ID: 34126409
[TBL] [Abstract][Full Text] [Related]
20. Evidence for participation of RNA 1-encoded elicitor in Cowpea mosaic virus-mediated concurrent protection.
Bruening G; Buzayan JM; Ferreiro C; Lim W
Virology; 2000 Jan; 266(2):299-309. PubMed ID: 10639316
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
